Rheumatoid Arthritis Treatment companies

Key Rheumatoid Arthritis Treatment Market Players:

The RA treatment market in 2024 is still quite consolidated. Pfizer and Amgen are at the forefront of biosimilar development, with quick approvals making treatments more affordable. Asian companies are making a name for themselves globally by offering cost-effective, high-quality biosimilars. Strategic partnerships are helping these companies expand their global reach.

Company Name	Country	2024 Market Share (%)
AbbVie Inc.	USA	27.2%
Pfizer Inc.	USA	11.7%
Amgen Inc.	USA	9.9%
Johnson & Johnson	USA	5.5%
Roche Holding AG	Switzerland	5.1%
Novartis AG	Switzerland	xx%
Eli Lilly & Co.	USA	xx%
Sanofi	France	xx%
UCB S.A.	Belgium	xx%
Biogen Inc.	USA	xx%
Bristol Myers Squibb	USA	xx%
Sandoz (Novartis Division)	Switzerland	xx%
Celltrion Inc.	South Korea	xx%
Biocon Biologics Ltd.	India	xx%
Samsung Bioepis	South Korea	xx%
Astellas Pharma Inc.	Japan	xx%
Daiichi Sankyo	Japan	xx%
CSL Limited	Australia	xx%
Pharmaniaga Berhad	Malaysia	xx%
Lupin Pharmaceuticals	India	xx%

Below are the areas covered for each company in the market: 

• Company Overview 
• Business Strategy 
• Key Product Offerings 
• Financial Performance 
• Key Performance Indicators 
• Risk Analysis 
• Recent Development 
• Regional Presence 
• SWOT Analysis